ChosenMed
Latest round
- Series C
Last raised
- Dec 2021
Total raised
- $16M
Investors
- 8
About ChosenMed
Based in Beijing, China and established in 2017, ChosenMed operates as an oncology precision medicine product and service provider that provides tumor genetic testing service. The company has many strategic partners, such as Illumina, Qiagen and Agena. ChosenMed has set up several standardized oncology NGS medical testing laboratories in Beijing, Hangzhou, Nanjing, Chongqing and Guangzhou. Dr. Wei Li, the Chief Scientist, is a tenured professor at the University of California, and the Chief Information Officer, Dr. Beifang Niu, is a researcher at the Chinese Academy of Sciences. ChosenMed provides oncology precision medicine product and service for early tumor screening, companion diagnosis, dynamic monitoring and prognostic evaluation fields. The product of the company includes solid tumor and blood tumor, such as chosenOne599® pan-cancer gene detection, chosenLung™ lung cancer 27 gene test and chosenHeme® blood tumor-related gene detection program. The company has mass spectrometry platform, micro-droplet digital polymerase chain reaction (PCR) platform and tumor high-throughput sequencing platform, such as novaseq 6000, miseq dx and nextseq 2000. The company has 57 patents and 62 life letter software copyrights. The company adopts genetic testing and artificial intelligence technology.
Who invested in ChosenMed
8 investors across 4 rounds
See all investors in ChosenMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ChosenMed
Who invested in ChosenMed?
ChosenMed has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ChosenMed raised?
ChosenMed has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did ChosenMed last raise money?
ChosenMed's most recent round on record is a Series C, in Dec 2021.
What does ChosenMed do?
Based in Beijing, China and established in 2017, ChosenMed operates as an oncology precision medicine product and service provider that provides tumor genetic testing service.
Where is ChosenMed headquartered?
ChosenMed is headquartered in Beijing, China.
Which VCs invest in companies like ChosenMed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at ChosenMed's stage. Their profiles are linked below.
VCs backing healthcare startups at Series C
Raising like ChosenMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.